Adenovirus mediated transfer of p53, GM-CSF and B7-1 suppresses growth and enhances immunogenicity of glioma cells

References

• Louis DN, Holland EC, Cairncross JG. Glioma classification: A molecular reappraisal. Am J Pathol 2001; 159: 779–786.
   PubMed Web of Science ®Google Scholar
• Fine HA, Dear KB, Loeffler JS, et al. Meta-analysis of radiationtherapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 1993; 71: 2585–2597.
   PubMed Web of Science ®Google Scholar
• Parney IF, Hao C, Petruk KC. Glioma immunology and immunotherapy. Neurosurgery 2000; 46: 778–791.
   PubMed Web of Science ®Google Scholar
• Jean WC, Spellman SR, Wallenfriedman MA, et al. Effects of combined granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2, and interleukin-12 based immunother-apy against intracranial glioma in the rat. J Neurooncol 2004; 66: 39–49.
   PubMed Web of Science ®Google Scholar
• Chen JC, Chen Y, Wu JM, et al. Effects of irradiated tumor vaccine and infusion of granulocyte-macrophage colony-stimulat-ing factor and interleukin-12 on established gliomas in rats. Cancer Immunol Immunother 2006; 55: 873–883.
   PubMed Web of Science ®Google Scholar
• Parney IF, Farr-Jones MA, Koshal A, et al. Human brain tumorcell culture characterization after immunostimulatory gene trans-fer. Neurosurgery 2002; 50: 1094–1102.
   PubMed Web of Science ®Google Scholar
• Chong H, Todryk S, Hutchinson G, et al. Tumour cell expressionof B7 costimulatory molecules and interleukin-12 or granulocyte-macrophage colony-stimulating factor induces a local antitumour response and may generate systemic protective immunity. Gene Ther 1998; 5: 223–232.
   PubMed Web of Science ®Google Scholar
• Ward SG. CD28: A signalling perspective. Biochem J 1996; 318: 361–377.
   PubMed Web of Science ®Google Scholar
• Levine AI p53, the cellular gatekeeper for growth and division. Cell 1997; 88: 323–331.
   PubMed Web of Science ®Google Scholar
• Vousden KH. p53: Death star. Cell 2000; 103: 691–694.
   PubMed Web of Science ®Google Scholar
• Shinoura N, Muramatsu Y, Asai A, et al. Degree of apoptosis induced by adenovirus-mediated transduction of p53 or p73alpha depends on the p53 status of glioma cells. Cancer Lett 2000; 160: 67–73.
   PubMed Web of Science ®Google Scholar
• Haas-Kogan DA, Kogan SS, Yount G, et al. p53 function influences the effect of fractionated radiotherapy on glioblastoma tumors. Int j Radiat Oncol Biol Phys 1999; 43: 399–403.
   PubMed Web of Science ®Google Scholar
• Xiang W, Zhu X, Zhao H. The effects of wild-type p53 gene transfection on the growth and chemotherapeutic sensitivity of human glioma cells. J Huazhong Univ Sci Technolog Med Sci 2002; 22: 44–46.
   PubMedGoogle Scholar
• Lang FF, Yung WK, Sawaya R, et al. Adenovirus-mediated p53 gene therapy for human gliomas. Neurosurgery 1999; 45: 1093–1104.
   PubMed Web of Science ®Google Scholar
• Li H, Lochmuller H, Yong VW, et al. Adenovirus-mediated wild-type p53 gene transfer and overexpression induces apoptosis of human glioma cells independent of endogenous p53 status. J Neuropathol Exp Neurol 1997; 56: 872–878.
   PubMed Web of Science ®Google Scholar
• Li H, Alonso-Vanegas M, Colicos MA, et al. Intracerebral adenovirus-mediated p53 tumor suppressor gene therapy for experimental human glioma. Clin Cancer Res 1999; 5: 637–642.
   PubMed Web of Science ®Google Scholar
• Cirielli C, Inyaku K, Capogrossi MC, et al. Adenovirus-mediated wild-type p53 expression induces apoptosis and suppresses tumorigenesis of experimental intracranial human malignant glioma. J Neurooncol 1999; 43: 99–108.
   PubMed Web of Science ®Google Scholar
• Lang FF, Bruner JM, Fuller GN, et al. Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: Biological and clinical results. J Clin Oncol 2003; 21: 2508–2518.
   PubMed Web of Science ®Google Scholar
• Hathcock KS, Laszlo G, Pucillo C, et al. Comparative analysis of B7-1 and B7-2 costimulatory ligands: Expression and function. J Exp Med 1994; 180: 631–640.
   PubMed Web of Science ®Google Scholar
• Judge TA, Tang A, Turka LA. Immunosuppression through blockade of CD28:B7-mediated costimulatory signals. Immunol Res 1996; 15: 38–49.
   PubMed Web of Science ®Google Scholar
• Morioka J, Kajiwara K, Yoshikawa K, et al. Adenovirus-mediated gene transfer of B7.1 induces immunological anti-tumor effects in a murine brain tumor. J Neurooncol 2002; 60: 13–23.
   PubMed Web of Science ®Google Scholar
• Joki T, Kikuchi T, Akasaki Y, et al. Induction of effective antitumor immunity in a mouse brain tumor model using B7-1 (CD80) and intercellular adhesive molecule 1 (ICAM-1; CD54) transfection and recombinant interleukin 12. Int J Cancer 1999; 82: 714–720.
   PubMed Web of Science ®Google Scholar
• Komata T, Tanaka R, Yamamoto K, et al. B7-1(CD80)-transfected human glioma cells and interleukin-12 directly stimu-late allogeneic CD8± T cells. J Immunother 1997; 20: 256–264.
   PubMed Web of Science ®Google Scholar
• Visse E, Siesjo P, Widegren B, et al. Regression of intracerebral rat glioma isografts by therapeutic subcutaneous immunization with interferon-gamma, interleukin-7, or B7-1-transfected tumor cells. Cancer Gene Ther 1999; 6: 37–44.
   PubMed Web of Science ®Google Scholar
• Levitsky HI, Montgomery J, Ahmadzadeh M, et al. Immunization with granulocyte-macrophage colony-stimulating factor-transduced, but not B7-1-transduced, lymphoma cells primes idiotype-specific T cells and generates potent systemic antitumor immunity. J Immunol 1996; 156: 3858–3865.
   PubMed Web of Science ®Google Scholar
• Simons JW, Jaffee EM, Weber CE, et al. Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer. Cancer Res 1997; 57: 1537–1546.
   PubMed Web of Science ®Google Scholar
• Dranoff G. GM-CSF-based cancer vaccines. Immunol Rev 2002; 188: 147–154.
   PubMed Web of Science ®Google Scholar
• Prell RA, Li B, Lin JM, et al. Administration of IFN-alpha enhances the efficacy of a granulocyte macrophage colony stimulating factor-secreting tumor cell vaccine. Cancer Res 2005; 65: 2449–2456.
   PubMed Web of Science ®Google Scholar
• Plautz GE, Barnett GH, Miller DW, et al. Systemic T cell adoptive immunotherapy of malignant gliomas. J Neurosurg 1998; 89: 42–51.
   PubMed Web of Science ®Google Scholar
• Sloan AE, Dansey R, Zamorano L, et al. Adoptive immunother-apy in patients with recurrent malignant glioma: Preliminary results of using autologous whole-tumor vaccine plus granulocyte-macrophage colony-stimulating factor and adoptive transfer of anti-CD3-activated lymphocytes. Neurosurg Focus 2000; 9: e9.
   PubMedGoogle Scholar
• Ren SP, Wu CT, Huang WR, et al. Adenoviral-mediated transfer of human wild-type p53, GM-CSF and B7-1 genes results in growth suppression and autologous anti-tumor cytotoxicity of multiple myeloma cells in vitro. Cancer Immunol Immunother 2006; 55: 375-385.
   Google Scholar
• Shi M, Wang FS, Wu ZZ. Synergetic anticancer effect of combinedquercetin and recombinant adenoviral vector expressing human wild-type p53, GM-CSF and B7-1 genes on hepatocellular carcinoma cells in vitro. World J Gastroenterol 2003; 9: 73–78.
   PubMed Web of Science ®Google Scholar
• Qiu Z, Lao M, Wu C. Co-transfer of human wild-type p53 and granulocyte-macrophage colony-stimulating factor genes via recombinant adenovirus induces apoptosis and enhances immuno-genicity in laryngeal cancer cells. Cancer Lett 2001; 167: 25–32.
   PubMed Web of Science ®Google Scholar
• Parney IF, Farr-Jones MA, Petruk KC. Improved technique for establishing short term human brain tumor cultures. J Neurooncol 1999; 43: 1–10.
   PubMed Web of Science ®Google Scholar
• Gomez-Manzano C, Fueyo J, Kyritsis AP, et al. Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis. Cancer Res 1996; 56: 694–699.
   PubMed Web of Science ®Google Scholar
• Choi KJ, Kim JH, Lee YS, et al. Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect. Gene Ther 2006; 13: 1010–1020.
   PubMed Web of Science ®Google Scholar
• Danthinne X, Imperiale MJ. Production of first generation adenovirus vectors: A review. Gene Ther 2000; 7: 1707–1714.
   PubMed Web of Science ®Google Scholar
• Kay MA, Glorioso JC, Naldini L. Viral vectors for gene therapy: The art of turning infectious agents into vehicles of therapeutics. Nat Med 2001; 7: 33–40.
   PubMed Web of Science ®Google Scholar
• Sandmair AM, Loimas S, Puranen P, et al. Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses. Hum Gene Ther 2000; 11: 2197–2205.
   PubMed Web of Science ®Google Scholar
• Ito H, Aoki H, Kuhnel F, et al. Autophagic cell death of malignantglioma cells induced by a conditionally replicating adenovirus. J Natl Cancer Inst 2006; 98: 625–636.
   PubMed Web of Science ®Google Scholar